Clinical Trial Update: Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on chemoradiotherapy for oesophageal cancer, including PET response assessment and dose escalation in a combined Phase 2/Phase 3 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Lisette Nixon | Conditions: Oesophageal Cancer | Phase 2, Phase 3 | Status: UNKNOWN